December 6, 2019
ARLINGTON, Va. — In 2018, sales through pharmaceutical distributors increased by 6.7 percent, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for 44.6 percent of all sales, a slight increase from 2017. Distributor margins, however, continued a four-year slide, though they showed increases in efficiency.
“For nearly a century, the Factbook has helped to inform the business decisions of supply chain leaders, experts and other stakeholders,” said Perry Fri, Executive Vice President of Industry Relations, Membership and Education, HDA; and COO of the HDA Research Foundation. “The 2019 edition illustrates how every day, distributors are innovating to deliver hundreds of millions of medicines and healthcare products — safely, reliably and efficiently.”
Primary data for the HDA Factbook are collected through an annual survey of HDA-member distributor companies with sales greater than $1 billion. Supplementary information also is included from healthcare and governmental organizations.
Also noted in the Factbook:
Other information detailed in the publication includes distributor demographics and characteristics, finance, information systems, market characteristics, operations and more.
The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) is produced with support from gold sponsors Apotex Corp. and Real Value Rx dba Hospital Pharmaceutical Consulting; and bronze sponsors IQVIA, Pharmacy First and Teva Pharmaceuticals.
The publication is available to download through the HDA website.
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization of the Healthcare Distribution Alliance (HDA). The Foundation serves the healthcare industry by providing research and education focused on healthcare supply chain issues. The Foundation’s mission is to conduct research and disseminate information that will enhance the knowledge base, efficiency and effectiveness of the total healthcare supply chain; and to provide thought leadership to further enhance the safety and security of the healthcare supply chain through future-focused study and programming.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.